Duratia 30 Mg 10 tablets

$6.50

Each Duratia contains 30 mg Dapoxetine 10 tablets per box, used to treat premature ejaculation in adult men aged 18 to 64 years.

ACT Classification: G04BX14
Active Ingrediant: Dapoxetine
Generic Name: Duratia 30
Manufacturer: Centurion
Strength: 30 Mg
Dosage Type: Tablet-CT
Packaging Type: Foil in Box
Contains:  10Tab

Examples of Packages sent

Free worldwide shipping on all orders over $50

  • 30 days easy returns
  • Order yours before 2.30pm for same day dispatch
Guaranteed Safe Checkout

Duratia 30 Mg 10 tablets
$6.50

[wpforms id=”1190″ title=”true” description=”Request a call back”]

Medication Safety Issues

Sound-alike/look-alike issues:

Dapoxetine may be confused with PARoxetine.

Contraindications

Hypersensitivity to dapoxetine or any component of the formulation; significant cardiac conditions including heart failure (class II-IV), conduction abnormalities (eg, AV block, sick sinus syndrome), significant ischemic or valvular heart disease, or history of syncope; history of mania or severe depression; moderate to severe hepatic impairment; concomitant use of strong CYP3A4 inhibitors; use with MAO inhibitors, other SSRIs, SNRIs, TCAs, thioridazine, or medicinal and herbal products with serotonergic effects (concurrently, within 7 days of discontinuing dapoxetine, or within 14 days of discontinuing the MAO inhibitor, SSRI, SNRI, TCA, thioridazine, or serotonergic medicinal or herbal product)

 

Product Availability (US)

Not available in US

Storage/Stability

Store at controlled room temperature.

Adverse Reactions

Frequency not always defined.

Cardiovascular: Flushing (1% to <10%), increased blood pressure (1% to <10%), palpitation

Central nervous system: Dizziness (6% to 11%), headache (6% to >10%), abnormal dreams (1% to <10%), agitation (1% to <10%), anxiety (1% to <10%), drowsiness (1% to <10%), irritability (1% to <10%), lack of concentration (1% to <10%), paresthesia (1% to <10%), restlessness (1% to <10%), yawning (1% to <10%), fatigue (1% to <10%), insomnia (1% to <10%), withdrawal syndrome (mild)

Dermatologic: Hyperhidrosis (1% to <10%)

Endocrine & metabolic: Decreased libido (≤10%)

Gastrointestinal: Nausea (11% to 22%; dose related), abdominal distention (1% to <10%), abdominal pain (1% to <10%), constipation (1% to <10%), diarrhea (1% to <10%), dyspepsia (1% to <10%), flatulence (1% to <10%), stomach discomfort (1% to <10%), upper abdominal pain (1% to <10%), vomiting (1% to <10%), xerostomia (1% to <10%)

Genitourinary: Erectile dysfunction (1% to <10%)

Neuromuscular & skeletal: Tremor (1% to <10%)

Ophthalmic: Blurred vision (1% to <10%)

Otic: Tinnitus (1% to <10%)

Respiratory: Sinus congestion (1% to <10%)

<1%, postmarketing, and/or case reports: Abnormality in thinking, akathisia, anorgasmia, apathy, bowel urgency, bruxism, confusion, depression, diaphoresis, disorientation, dysgeusia, ejaculation failure, epigastric distress, euphoria, eye pain, feeling abnormal, feeling hot, hot flash, hypersomnia, hypervigilance, hypotension, impaired consciousness, increased diastolic blood pressure, increased heart rate, intoxicated feeling, jitteriness, lethargy, mood changes, mydriasis, nervousness, nightmares, orgasm disturbance (male), orthostatic hypertension, orthostatic hypotension, paresthesia genital male, pruritus, sinoatrial arrest, sinus bradycardia, sleep disorder, sudden onset of sleep, syncope, systolic hypertension, tachycardia, vertigo, visual disturbance, weakness

Additional information

Active Ingrediant

Generic Name

Alternate Names

, , , , , , , , , , , , , , , , , , , , , ,

Strength

Dosage Type

Packaging Type